Pharma Industry News

Affimed ties with Roche in cancer immunotherapies deal

Shares in Affimed more than doubled on news that it has signed a deal with Roche group Genentech to develop immunotherapies for various cancers.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]